While it has been a typical reporting season, there is a group of stocks where results were surprisingly good, but the market still appears to be under-valuing them. Here are three representatives from this group.
The mining heavyweights have been a lucrative source of fully franked dividends and while last week was something of a shock for investors who rely on the dividend flow from the big miners, they do still boast attractive expected dividend yields, though it’s getting harder to find value. Here’s how analysts see the trio of BHP, Fortescue and Rio Tinto, for now.
It made a massive splash last week, but is Sigma Healthcare worth buying?
The price of gold surged 34% last year and is already 9% higher this year, having notched a fresh record high of US$2,866.20 an ounce last month, making this a wonderful operating environment for gold miners. But investors have realised this, and most goldminers have been bid up by the share market to very full prices. But here are two ASX-listed miners where the analysts’ consensus price target implies that there’s still good value to be found.
Is there value in the S&P/ASX 20 right now? Here’s a look at four ‘buy’ prospects from the ASX’s top echelon: Telstra, Rio Tinto, BHP and CSL.
Here are two Australian medical device companies doing impressive things in the medical imaging area in Australia and the US.
If you’re looking for capital growth, it can be quite rewarding to take a flutter on the more speculative end of the market, using funds you can afford to lose. Here are two of those stocks but remember the risk!
Here are three stocks I like, but that have blotted their copybooks recently.
Here are two more stocks that I’d be delighted to find in my Christmas stocking.
Here are two more stocks that I would be delighted to find in my stocking.
You don't have credit card details available. You will be redirected to update payment method page. Click OK to continue.